Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples